# Mike Flanagan

> Mike Flanagan is a Series A investor at Michigan Angel Fund backing Health Care and Life Science. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Michigan Angel Fund](https://shizune.co/investors/profile/michigan-angel-fund)
- Location: Ann Arbor, United States
- Total investments: 4
- Last investment: May 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/mike-flanagan-8a05569/
- X (Twitter): https://twitter.com/mflanaga105

Mike Flanagan is a Managing Director & Co-founder at Michigan Angel Fund company. He attended at University of Michigan.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Life Science | 1 | 25% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Funding Round | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 25% |
| Russian Federation | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Culturewell | Cleanliness Analytics - helping healthcare systems prevent infections in their facilities | $750K |  | May 29, 2026 |  |
| Culturewell | Cleanliness Analytics - helping healthcare systems prevent infections in their facilities | $750K |  | May 29, 2026 |  |
| Culturewell | Cleanliness Analytics - helping healthcare systems prevent infections in their facilities | $1.4M | Seed | Nov 03, 2023 |  |
| Flightpath Biosciences | Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.The company is bridging scientific unknowns by interrogating disparate fields of biology, taking risks, innovating, and deploying potentially orthogonal approaches to achieve desired outcomes. It is working with leading scientists,therapeutics, and diagnostics experts across multiple scientific disciplines within several esteemed academic institutions and government agencies to create novel, targeted solutions.The company was founded in 2019 and is based in Berkeley, California. | $8.1M | Series A | Feb 15, 2023 |  |

4 of 4 investments shown.

## Co-investors
- [Michigan Rise](https://shizune.co/investors/profile/michigan-rise) — VC Fund, 5 deals together
- [Biosciences Research and Commercialization Center (BRCC)](https://shizune.co/investors/profile/biosciences-research-and-commercialization-center-brcc) — VC Fund, 3 deals together
- [Michigan Angel Fund](https://shizune.co/investors/profile/michigan-angel-fund) — VC Fund, 2 deals together
- [Ann Arbor SPARK](https://shizune.co/investors/profile/ann-arbor-spark) — VC Fund, 1 deal together

## About Michigan Angel Fund

VC Fund · Ann Arbor, United States

Michigan Angel Fund specializes in investments in angel deals. The fund does not invest in gaming or real estate related ventures. It prefers investing in early-stage start-ups that are at or near revenue. The fund seeks to invest in IT, CleanTech, advanced manufacturing, and health care. The fund invests between $0.2 million to $2 million in itscompanies. It prefers investing in companies requiring less than $2 million to reach break-even or sustainability.Founded in 2011, Michigan Angel Fund is headquartered in Ann Arbor, Michigan.

5 contacts available at Michigan Angel Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Christopher Couch | Angel Investor | https://shizune.co/investors/profile/christopher-couch-3427 |
| David Peralta | Limited Partner | https://shizune.co/investors/profile/david-peralta |
| Joseph Simms | Managing Partner | https://shizune.co/investors/profile/joseph-skip-simms |
| Mike Flanagan | Managing Director & Co-founder | https://shizune.co/investors/profile/mike-flanagan |
| Skip Simms | Managing Member | https://shizune.co/investors/profile/skip-simms |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Mike Flanagan invest in?

Mike Flanagan invests primarily in Health Care, Life Science and Therapeutics startups, most often at Series A and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mike Flanagan last invest?

The most recent investment recorded for Mike Flanagan closed in May 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co